Arch Therapeutics, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
S-1/A: Arch Therapeutics Eyes Cboe Listing with Unit Offering, Aims to Bolster Commercialization Efforts
Arch Therapeutics is undertaking a unit offering to support its Cboe listing application and fuel the commercial rollout of its AC5 Advanced Wound System.